Variables | Patients in the training set, n = 226 | Patients in the validation set, n = 113 | Patients in the testing set, n = 116 | χ2(p) |
---|---|---|---|---|
Age(years) | 30(16-62) | 35(16-75) | 32(16-74) | 1.741(0.419) |
WBC(109/L) | 5.4(1.3-18.1) | 5.5(2.5-16.8) | 5.4(3.0-11) | 0.231(0.891) |
RBC(1012/L) | 4.7(2.6-4.0) | 4.7(3.6-5.7) | 4.6(3.7-5.6) | 0.310(0.856) |
Platelet(109/L) | 165(53-246) | 170(13-350) | 185(46-345) | 4.965(0.083) |
ALT(U/L) | 87(16-471) | 80(11-536) | 72(6-507) | 2.475(0.290) |
AST(U/L) | 48(11-413) | 42.5(15-375) | 39(11-361) | 1.264(0.531) |
GGT(U/L) | 29(6-421) | 33(6-288) | 34(10-473) | 3.247(0.197) |
ChE(U/L) | 8402(50-20427) | 7674(145-11374) | 7258(360-12648) | 3.051(0.217) |
Alb(g/L) | 44.8(10.9-47.0) | 44.2(11.8-50.7) | 44.1(31.3-52.6) | 0.412(0.814) |
TBIL(μmol/L) | 14.1(3.6-216) | 15.3(3-196) | 13.2(3- 134) | 3.650(0.161) |
Fibrosis F(0-1)/F(2-4) | 166/60 | 83/30 | 80/36 | 0.657(0.720) |